SUNPHARMA

Sun Pharmaceutical Industries Balance Sheet

₹1,773.60-1.69%
Market cap
₹4.26 lakh crore
P/E
35.2
P/B
5.09
ROE
14.7%
Dividend yield
0.28%

As of Mar 2022, Sun Pharmaceutical Industries had total assets of ₹13,700 crore and borrowings of ₹1,200 crore, against shareholders' equity of ₹9,000 crore — a debt-to-equity ratio of 0.13. Borrowings fell 82.57% from Mar 2023.

Sun Pharmaceutical Industries balance sheet

As at each financial year end, newest first. H1 = half-year.

Sun Pharmaceutical Industries balance sheet (₹ crore)
ItemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital500240240240240
Reserves8,50043,61050,15557,86269,355
Borrowings1,2006,8863,2742,3624,627
Other liabilities3,50014,54215,10017,25220,278
Total liabilities13,70080,74485,50092,1011,08,785
Fixed assets6,50011,48411,48911,48712,637
Capital work in progress400100100100100
Investments2,50016,14917,10018,42021,757
Other assets4,30024,22325,65027,63032,636
Total assets13,70080,74485,50092,1011,08,785

Balance sheet ratios

Debt to equity
0.13

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Sun Pharmaceutical Industries balance sheet — frequently asked questions

What is the total debt of Sun Pharmaceutical Industries?

Sun Pharmaceutical Industries reported borrowings of ₹1,200 crore as of Mar 2022, compared with ₹6,886 crore as of Mar 2023.

What is Sun Pharmaceutical Industries' debt-to-equity ratio?

Based on the Mar 2022 balance sheet, Sun Pharmaceutical Industries' debt-to-equity ratio is 0.13 — borrowings of ₹1,200 crore against equity capital and reserves of ₹9,000 crore.

What are Sun Pharmaceutical Industries' total assets?

Sun Pharmaceutical Industries' total assets were ₹13,700 crore as of Mar 2022, including fixed assets of ₹6,500 crore and investments of ₹2,500 crore.

Same Data For Peers

Trade Sun Pharmaceutical Industries With ATS

Track SUNPHARMA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.